Results
ADVERSE EVENTS
This study was initiated on January 22, 2020, but enrolment was halted on March 16, 2020 due to the COVID-19 pandemic and specific COVID-19 prevention measures instituted in Belgium at that time; the study resumed on July 27, 2020, with completion on February 1, 2021. A total of 152 volunteers were enrolled, of whom 87 were randomized to one of three groups to receive one dose of either IPV alone (n = 32), IPV + dmLT (n = 33) or bOPV (n = 22). As shown in Study flow chart.Demographics of the total vaccinated study population.Unsolicited adverse events in the total vaccinated study population up to Day 29.